Skip to content

Clinical trials

Completed Phase 2 Lymphoma, B-Cell, Marginal Zone trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 2 Status: Completed Clear all

172 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200015
20016
20025
20038
200412
200514
20067
20079
20088
20094
20104
20117
20123
20133
20152
20179
20182
20193
20204
20213
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed172

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center27
National Cancer Institute (NCI)11
Memorial Sloan Kettering Cancer Center9
Case Comprehensive Cancer Center7
Mayo Clinic6
Roswell Park Cancer Institute6
Jonsson Comprehensive Cancer Center5
M.D. Anderson Cancer Center5
Masonic Cancer Center, University of Minnesota5
University of Nebraska5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone172
Lymphoma, Follicular145
Leukemia, Lymphocytic, Chronic, B-Cell135
Lymphoma, Mantle-Cell117
Lymphoma, Non-Hodgkin111
Lymphoma, Large B-Cell, Diffuse105
Burkitt Lymphoma96
Lymphoma93
Lymphoma, Large-Cell, Immunoblastic91
Precursor Cell Lymphoblastic Leukemia-Lymphoma90

Trials

Showing 1 to 25 of 172. Each trial links to its page on Pharma Observatory.

72 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.